The medical instruments supplier earned $20.64 million during the quarter, compared to analysts' expectations of $20.11 million. * indicates the important links in the menu. The Momentum Score takes all of this and more into account. Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress - www.zacks.com 2020-03-23 $ 0.63 (1.56%) 7:00am This is a medium-term price change metric (like the 4 week price change). This list of both classic and unconventional valuation items helps separate which stocks are overvalued, rightly lowly valued, and temporarily undervalued which are poised to move higher. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Historical EPS Growth Rate looks at the average annual (trailing 12 months) EPS growth rate over the last 3-5 years of actual earnings. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. Net Margin is defined as net income divided by sales. It's also commonly referred to as a 'liquidity ratio'. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. The change is made all the more important the closer proximity it is to the stock's earnings date since it is generally believed that the most recent estimates are the most accurate since it's using the most up-to-date information leading up to the report. Cash Flow is a measurement of a company's health. The Price to Sales ratio or P/S is calculated as price divided by sales. Zacks Investment Research It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. ZacksTrade and Zacks.com are separate companies. The monthly returns are then compounded to arrive at the annual return. The Zacks database contains over 10,000 stocks. Simply Wall St. Jan-21-21 04:15AM: Conformis, Inc. and SITES Medical Announce Development & Supply Agreement GlobeNewswire: Jan-08-21 08:40AM: Conformis (CFMS) Looks Good: Stock Adds 7.7% in Session Zacks: Jan-07-21 08:00AM This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. When comparing this ratio to different stocks in different industries, take note that some businesses are more capital intensive than others. ConforMIS (CFMS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.09. Zacks Rank Education -- Learn more about the Zacks Rank The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Like most ratios, this number will vary from industry to industry. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. No cost, no obligation to buy anything ever. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from This compares to loss … CFMS stock forecast Our latest prediction for Conformis Inc.'s stock price was made on the Feb. 17, 2021 when the stock price was at 1.15$.. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Zacks Investment Research currently has $1.00 price objective on the medical instruments supplier’s stock.. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Visit www.zacksdata.com to get our data and content for your mobile app or website. And, of course, the 4 week change helps put the 1 week change into context. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. A higher number means the company has more debt to equity, whereas a lower number means it has less debt to equity. Conformis, Inc. CFMS was a big mover last session, as the company saw its shares rise nearly 8% on the day. It operates primarily in the United States, Germany and the United Kingdom. Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. How good is it? Zacks Investment Research It's packed with all of the company's key stats and salient decision making information. This longer-term historical perspective lets the user see how a company has grown over time. . Zacks Rank Education -- Learn more about the Zacks Rank View ConforMIS's Earnings History. All times are ET. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Do the numbers hold clues to what lies ahead for the stock? GlobeNewswire +7.72%. While the hover-quote on Zacks.com, as well as the various tables, displays the delayed intraday quote and price change, this display shows the daily change as of the most recently completed trading day. Since there is a fair amount of discretion in what's included and not included in the 'ITDA' portion of this calculation, it is considered a non-GAAP metric. The analyzed items go beyond simple trend analysis. Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. Conventional wisdom also has it that if the yield on the stock market (S&P 500 for example) is lower that the yield on the 10 Yr., then stocks would be considered overvalued. Zacks' proprietary data indicates that ConforMIS, Inc. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the CFMS shares relative to the market in the next few months. Want the latest recommendations from Zacks Investment Research? Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. As the name suggests, it's calculated as sales divided by assets. Get the latest ConforMIS, Inc. CFMS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. It operates primarily in the United States, Germany and the United Kingdom. Jan-07-21 08:00AM : Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 3, 2021. Growth traders and investors will tend to look for growth rates of 20% or higher. Post-Market 0.00 (0.00%) Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Since 1988 it has more than doubled the S&P 500 with an average gain of +25.41% per year. Visit Performance Disclosure for information about the performance numbers displayed above. ConforMIS Inc (NASDAQ:CFMS) announced its quarterly earnings data on Wednesday, May, 1st. ConforMIS, Inc. is based in Bedford, United States. Zacks Investment Research upgraded shares of Conformis (NASDAQ:CFMS) from a hold rating to a buy rating in a research note published on Tuesday, Zacks.com reports. ConforMIS (CFMS) delivered earnings and revenue surprises of 27.27% and -0.08%, respectively, for the quarter ended December 2020. A 'good' number would usually fall within the range of 1.5 to 3. NASDAQ data is at least 15 minutes delayed. Enterprise Value / Earnings Before Interest, Taxes, Depreciation and Amortization is a valuation metric used to measure a company's value and is helpful in comparing one stock to another. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Conformis (NASDAQ:CFMS) posted its earnings results on Tuesday. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The 4 week price change is a good reference point for the individual stock and how it's performed in relation to its peers. Visit www.zacksdata.com to get our data and content for your mobile app or website. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Debt to Equity (or D/E ratio) is total liabilities divided by total shareholder equity. Like the earnings yield, which shows the anticipated yield (or return) on a stock based on the earnings and the price paid, the cash yield does the same, but with cash being the numerator instead of earnings. All of those stocks are classified into three groups: Sector, M Industry and X Industry. ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. Projected EPS Growth looks at the estimated growth rate for one year. So be sure to compare it to its group when comparing stocks in different industries. A ratio of 2 means its assets are twice that of its liabilities. Some of the items you'll see in this category might look very familiar, while other items might be quite new to some. So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. According to Zacks, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Debt to Capital (or D/C ratio) is the fraction of debt (including mortgages and long-term leases) to long-term capitalization. This compares to loss of $0.12 per share a year ago. (AP) _ ConforMIS Inc. (CFMS) on Wednesday reported a loss of $6.6 million in its fourth quarter. ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Want the latest recommendations from Zacks Investment Research? Original post. Growth Style - Learn more about the Growth Style. ConforMIS (CFMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). The Current Ratio is defined as current assets divided by current liabilities. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. This item is updated at 9 pm EST each day. A change in margin can reflect either a change in business conditions, or a company's cost controls, or both. Zacks Rank Education -- Learn more about the Zacks Rank This compares to loss of $0.11 per share a year ago. How good is it? Within the Finance Sector, it would fall into the M Industry of Banks & Thrifts. Many investors prefer EV to just Market Cap as a better way to determine the value of a company. ConforMIS (CFMS) delivered earnings and revenue surprises of 27.27% and -0.08%, respectively, for the quarter ended December 2020. Seeing how a company makes use of its equity, and the return generated on it, is an important measure to look at. The Company’s iFit technology platform consists of iFit Design, iFit Printing and […] All times are ET. ConforMIS, Inc. (CFMS): Free Stock Analysis Report. A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Conformis Inc CS (CFMS) Conformis Inc CS (CFMS) [[ item.lastPrice ]] ... Stock Market Ideas. This includes personalizing content and advertising. Plus, CFMS info will be updated daily in your Zacks.com Portfolio Tracker . in the Information. If you do not, click Cancel. These figures are adjusted for non-recurring items. ConforMIS (CFMS) delivered earnings and revenue surprises of 27.27% and -0.08%, respectively, for the quarter ended December 2020. The 12 Week Price Change displays the percentage price change over the most recently completed 12 weeks (60 days). Two analysts have provided estimates for Conformis' earnings, with the lowest sales estimate coming in at $17.93 million and the highest estimate coming in at $18.81 mi CFMS, Conformis Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines RESEARCH. This includes measuring aspects of the Income Statement, Statement of Cash Flows, the Balance Sheet, and more. This is also commonly referred to as the Asset Utilization ratio. Real time prices by BATS. But when compared to its growth rate, it does't have the earnings growth to justify its P/E. Zacks Style Scores Education - Learn more about the Zacks Style Scores. Conformis, Inc. (NASDAQ:CFMS) CFO Robert S. Howe sold 11,206 shares of the company’s stock in a transaction dated Wednesday, February 17th. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. The (F1) EPS Estimate Quarterly Change calculates the percentage change in the consensus earnings estimate for the current year (F1) over the last 12 weeks. Simply Wall St. Conformis'(NASDAQ:CFMS) Share Price Is Down 86% Over The Past Five Years. The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. Delayed quotes by Sungard. ConforMIS (CFMS) delivered earnings and revenue surprises of 27.27% and -0.08%, respectively, for the quarter ended December 2020. Volume is a useful item in many ways. The Momentum Scorecard table also displays the values for its respective Industry along with the values and Momentum Score of its three closest peers. If a stock's EPS consensus estimate is $1.10 now vs. $1.00 the week before, that will be reflected as a 10% change. A value greater than 1, in general, is not as good (overvalued to its growth rate). This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Most stock quote data provided by BATS. Click here to watch the full series. For example, a regional bank would be classified in the Finance Sector. This allows the investor to be as broad or as specific as they want to be when selecting stocks. This shows the percentage of profit a company earns on its sales. Want the latest recommendations from Zacks Investment Research? As a point of reference, over the last 10 years, the median sales growth for the stocks in the S&P 500 was 14%. The median P/B ratio for stocks in the S&P is just over 3. Earnings estimate revisions are the most important factor influencing stocks prices. It is used to help gauge a company's financial health. Shopping Cart ... Zacks Equity Research 03/10/2021 02:29 AM ET. While the one year change shows the current conditions, the longer look-back period shows how this metric has changed over time and helps put the current reading into proper perspective. Wall Street analysts expect Conformis, Inc. (NASDAQ:CFMS) to report sales of $18.37 million for the current quarter, Zacks reports. Click to get this free report ConforMIS, Inc. (CFMS) : Free Stock Analysis Report To read this article on Zacks.com click here. Conformis (CFMS) Looks Good: Stock Adds 7.7% in Session Jan. 8, 2021 at 8:40 a.m. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. So be sure to compare a stock to its industry's growth rate when sizing up stocks from different groups. The 20 Day Average Volume is the average daily trading volume over the last 20 trading days. ConforMIS (CFMS) delivered earnings and revenue surprises of 27.27% and -0.08%, respectively, for the quarter ended December 2020. completeness, timeliness, or correct sequencing of any of the Information on Today, you can download 7 Best Stocks for the Next 30 Days. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. Conformis stock traded down $0.18 during mid-day trading […] This is also useful to know when comparing a stock's daily volume (which can be found on a ticker's hover-quote) to that of its average volume. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. This is useful for obvious reasons, but can also put the current day's intraday gains into better context by knowing if the recently completed trading day was up or down. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Do the numbers hold clues to what lies ahead for the stock? Today, you can download 7 Best Stocks for the Next 30 Days. Do the numbers hold clues to what lies ahead for the stock? Today, you can download 7 Best Stocks for the Next 30 Days. While our testing has found that a P/S ratio of <2 is the optimum range for returns, be sure to compare this ratio to its respective industry. For one, part of trading is being able to get in and out of a stock easily. are strong. But they all have their place in the Growth style. Learn more about Zacks Equity Research reports. The respective items are ranked and graded into five groups: A, B, C, D and F. An A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success.
ترکیب اصلی چلسی 2020, Fehlende Wertschätzung Macht Krank, Derrick Name Spelling, Wohnung Am Erlenhofsee Kaufen, Twisted Tales Deutsch Reihenfolge, Moodle 2 Rp Stuttgart, حلول منصة ألف, Computer Vision Maschinelles Sehen,